CDC25C and hepatocellular carcinoma: Activated CHK1 then phosphorylates CDC25C, resulting in its inactivation and maintaining CDK1 in an inactive phosphorylated state, thereby arrested the cell cycle at G2/M phase to inhibit the malignant proliferation of HCC cells (Smith et al., 2020).